Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Masszi, András ^a,c   Di Ciano, Caterina ^a   Sirokmány, Gábor ^a   Arthur, William T ^e   Rotstein, Ori D ^a   Wang, Jiaxu ^b   McCulloch, Christopher A G ^b   Rosivall, László ^c   Mucsi, István ^c,d   Kapus, András ^a,f  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Epithelial mesenchymal transdifferentiation; Kidney proximal tubule cells; Rho kinase; Transforming growth factor 1

Indexed keywords

ALPHA ACTIN; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; GUANOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RHO FACTOR;

ANIMAL CELL; ARTICLE; ENZYME ASSAY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; INTERSTITIAL NEPHRITIS; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0037405501     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00183.2002     Document Type: Article

References (69)

1. Adam PJ, Regan CP, Hautmann MB, and Owens GK. Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem 275: 37798-37806, 2000.
2. Alberts AS, Geneste O, and Treisman R. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92: 475-487, 1998.
3. Amano M, Fukata Y, and Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp Cell Res 261: 44-51, 2000.
4. Arthur WT and Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 12: 2711-2720, 2001.
5. Arthur WT, Petch LA, and Burridge K. Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr Biol 10: 719-722, 2000.
6. Atfi A, Djelloul S, Chastre E, Davis R, and Gespach C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J Biol Chem 272: 1429-1432, 1997.
7. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, and Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810, 2000.
8. 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36, 2001.
9. Border WA and Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51: 1388-1396, 1997.
10. Bottinger EP and Bitzer M. TGF-β signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002.
11. Boukhalfa G, Desmouliere A, Rondeau E, Gabbiani G, and Sraer JD. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney, Exp Nephrol 4: 241-247, 1996.
12. 1/C14 cells transfected with the rabbit AT1 ANG II receptor. Am J Physiol Cell Physiol 268: C925-C935, 1995.
13. Chihara K, Amano M, Nakamura N, Yano T, Shibata M, Tokui T, Ichikawa H, Ikebe R, Ikebe M, and Kaibuchi K. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J Biol Chem 272: 25121-25127, 1997.
14. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996.
15. Edlund S, Landstrom M, Heldin CH, and Aspenstrom P. Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 13: 902-914, 2002.
16. Engel ME, Datta PK, and Moses HL. RhoB is stabilized by transforming growth factor β and antagonizes transcriptional activation. J Biol Chem 273: 9921-9926, 1998.
17. Engel ME, McDonnell MA, Law BK, and Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 274: 37413-37420, 1999.
18. Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 25: 39-50, 2001.
19. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, and Lan HY. Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999.
20. Fukata Y, Amano M, and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39, 2001.
21. Garat C, Van Putten V, Refaat ZA, Dessev C, Han SY, and Nemenoff RA. Induction of smooth muscle alpha-actin in vascular smooth muscle cells by arginine vasopressin is mediated by c-Jun amino-terminal kinases and p38 mitogen-activated protein kinase. J Biol Chem 275: 22537-22543, 2000.
22. 1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 282: L146-L154, 2002.
23. Grupp C, Lottermoser J, Cohen DI, Begher M, Franz HE, and Muller GA. Transformation of rat inner medullary fibroblasts to myofibroblasts in vitro. Kidney Int 52: 1279-1290, 1997.
24. Hall A. Rho GTPases and the actin cytoskeleton. Science 279: 509-514, 1998.
25. Hautmann MB, Adam PJ, and Owens GK. Similarities and differences in smooth muscle alpha-actin induction by TGF-β in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2049-2058, 1999.
26. Hautmann MB, Madsen CS, and Owens GK. A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272: 10948-10956, 1997.
27. Hill CS, Wynne J, and Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81: 1159-1170, 1995.
28. Hull RN, Cherry WR, and Weaver GW. The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro Cell Dev 12: 670-677, 1976.
29. 1: role of contraction. Am J Physiol Lung Cell Mol Physiol 276: L582-L595, 1999.
30. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, and Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
31. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, and Lan HY. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38: 761-769, 2001.
32. Kapus A, Szaszi K, Sun J, Rizoli S, and Rotstein OD. Cell shrinkage regulates Src kinases and induces tyrosine phosphorylation of cortactin, independent of the osmotic regulation of Na+/H+ exchangers. J Biol Chem 274: 8093-8102, 1999.
33. Krendel M, Gloushankova NA, Bonder EM, Feder HH, Vasiliev JM, and Gelfand IM. Myosin-dependent contractile activity of the actin cytoskeleton modulates the spatial organization of cell-cell contacts in cultured epitheliocytes. Proc Natl Acad Sci USA 96: 9666-9670, 1999.
34. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, and Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 276: 341-347, 2001.
35. Mack CP, Thompson MM, Lawrenz-Smith S, and Owens GK. Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res 86: 221-232, 2000.
36. Marinissen MJ, Chiariello M, and Gutkind JS. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 15: 535-553, 2001.
37. Massague J and Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19: 1745-1754, 2000.
38. Morissette MR, Sah VP, Glembotski CC, and Brown JH. The Rho effector, PKN, regulates ANF gene transcription in cardiomyocytes through a serum response element. Am J Physiol Heart Circ Physiol 278: H1769-H1774, 2000.
39. Mucsi I, Skorecki KL, and Goldberg HJ. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor β1 on gene expression. J Biol Chem 271: 16567-16572, 1996.
40. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, and Lan HY. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54: 864-876, 1998.
41. Noren NK, Niessen CM, Gumbiner BM, and Burridge K. Cadherin engagement regulates Rho family GTPases. J Biol Chem 276: 33305-33308, 2001.
42. Okada H, Danoff TM, Kalluri R, and Neilson EG. Early role of Fspl in epithelial-mesenchymal transformation. Am J Physiol Renal Physiol 273: F563-F574, 1997.
43. Oshiro N, Fukata Y, and Kaibuchi K. Phosphorylation of moesin by rho-associated kinase (Rho-kinase) plays a crucial role in the formation of microvilli-like structures. J Biol Chem 273: 34663-34666, 1998.
44. Pedagogos E, Hewitson T, Fraser I, Nicholls K, and Becker G. Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis 29: 912-918, 1997.
45. Petrov VV, Fagard RH, and Lijnen PJ. Stimulation of collagen production by transforming growth factor-β1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39: 258-263, 2002.
46. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, and West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 277: C1-C9, 1999.
47. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, and D'Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62: 137-146, 2002.
48. Remuzzi G, Ruggenenti P, and Benigni A. Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997.
49. Ronnov-Jessen L, Petersen OW, Koteliansky VE, and Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95: 859-873, 1995.
50. Sahai E, Alberts AS, and Treisman R. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17: 1350-1361, 1998.
51. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23:912-923, 2001.
52. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, and Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol 142: 873-881, 1998.
53. Serini G and Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 250: 273-283, 1999.
54. Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2: 827-837, 2001.
55. Shen X, Li J, Hu PP, Waddell D, Zhang J, and Wang XF. The activity of guanine exchange factor NET1 is essential for transforming growth factor-β-mediated stress fiber formation. J Biol Chem 276: 15362-15368, 2001.
56. Shimizu RT, Blank RS, Jervis R, Lawrenz-Smith SC, and Owens GK. The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem 270: 7631-7643, 1995.
57. Sotiropoulos A, Gineitis D, Copeland J, and Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98: 159-169, 1999.
58. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, and Neilson EG. Identification and characterization of a fibroblast marker: FSP1, J Cell Biol 130: 393-405, 1995.
59. Szaszi K, Kurashima K, Kapus A, Paulsen A, Kaibuchi K, Grinstein S, and Orlowski J. RhoA and rho kinase regulate the epithelial Na+/H+ exchanger NHE3. Role of myosin light chain phosphorylation. J Biol Chem 275: 28599-28606, 2000.
60. Takai Y, Sasaki T, and Matozaki T. Small GTP-binding proteins. Physiol Rev 81: 153-208, 2001.
61. Tang WW, Van GY, and Qi M. Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int 51: 926-931, 1997.
62. Tatsis N, Lannigan DA, and Macara IG. The function of the p190 Rho GTPase-activating protein is controlled by its N-terminal GTP binding domain. J Biol Chem 273: 34631-34638, 1998.
63. Wang J, Su M, Fan J, Seth A, and McCulloch CA. Transcriptional regulation of a contractile gene by mechanical forces applied through integrins in osteoblasts. J Biol Chem 277: 22889-22895, 2002.
64. Weed SA and Parsons JT. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20: 6418-6434, 2001.
65. Wilde C and Aktories K. The Rho-ADP-ribosylating C3 exoenzyme from Clostridium botulinum and related C3-like transferases. Toxicon 39: 1647-1660, 2001.
66. Yang J and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001.
67. Yang J and Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107, 2002.
68. Zhang G, Moorhead PJ, and el Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 3: 308-318, 1995.
69. Zhong C, Kinch MS, and Burridge K. Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells. Mol Biol Cell 8: 2329-2344, 1997.